Document ID: chunk:federal_register_of_legislation:F2025C00036:front:0:p8
Version: federal_register_of_legislation:F2025C00036
Segment Type: other
Provision Reference: 
Character Range: 21161–24386

of Schedule 1
Division 18—Application provisions relating to Schedule 1 to the Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations 2022
86 Extemporaneously‑compounded medicinal cannabis products
Division 19—Application provisions relating to Schedule 2 to the Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations 2022
87 Reconsideration of decisions
Division 20—Application provisions relating to the Therapeutic Goods Legislation Amendment (2022 Measures No. 3) Regulations 2022
88 Exempt goods
89 Fee for requests to vary entries in Register
Division 21—Application provisions relating to the Therapeutic Goods Legislation Amendment (2023 Measures No. 1) Regulations 2023
90 Clinical trials
Division 22—Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2023 Measures No. 2) Regulations 2023
91 Clinical trials
92 Removal of exemptions for sunscreen preparations
Division 23—Transitional provisions relating to the Therapeutic Goods Legislation Amendment (Vaping) Regulations 2023
93 Definitions
94 Approving supply of therapeutic goods under authorised prescriber scheme
95 Goods to be included in parts of the Register
96 Exempt goods
97 Transitional vaping manufacturers—exemption from Part 3‑3 of the Act
Division 24—Application provision relating to the Therapeutic Goods Amendment (2024 Measures No. 1) Regulations 2024
98 Exempt goods
Division 25—Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2024 Measures No. 2) Regulations 2024
99 Definitions
100 Fee waivers in relation to the Medicines Repurposing Program
101 Examination, testing and analysis of goods
102 Identity cards
103 Sunscreen preparations
Division 26—Application and transitional provisions relating to the Therapeutic Goods Legislation Amendment (Vaping Reforms) Regulations 2024
104 Definitions
105 Authorities for therapeutic vaping substances that are not medicines
106 Therapeutic vaping packs
107 Exempt goods
108 Transitional vaping goods—exemption from Part 3‑2 of the Act
Division 27—Application, transitional and saving provisions relating to the Therapeutic Goods Legislation Amendment (2024 Measures No. 3) Regulations 2024
109 Definitions
110 Exempt therapeutic goods
111 Notices, statements and determinations
Schedule 1—Part 2 does not apply to members of an Australian branch of one of these bodies
Schedule 2—Prohibited and required representations
Part 1—Prohibited representations
Part 2—Required representations
Part 3—Vitamins referred to in Item 3 of Part 1 of this Schedule
Schedule 3—Therapeutic goods required to be included in the part of the Register for goods known as registered goods or as provisionally registered goods
Part 1—Medicines
Part 2—Therapeutic goods that are not medicines
Part 3—Therapeutic goods attracting no fee under Division 1 or 2 of Part 3‑2 of the Act
Schedule 4—Therapeutic goods required to be included in the part of the Register for listed goods
Schedule 5—Therapeutic goods exempt from the operation of Parts 3‑2 and 3‑2A of the Act
Schedule 5A—Therapeutic goods exempt from operation of Parts 3‑2 and 3‑2A of Act subject to conditions
Schedule 5B—Disposal of unused emergency goods and